Vaxcyte, Inc. PCVX CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s capex?
- Vaxcyte, Inc. (PCVX) reported capex of $2.11M in Q1 2026.
- How has Vaxcyte, Inc.'s capex changed year-over-year?
- Vaxcyte, Inc.'s capex decreased by 61.2% year-over-year, from $5.42M to $2.11M.
- What is the long-term trend for Vaxcyte, Inc.'s capex?
- Over 3 years (2021 to 2025), Vaxcyte, Inc.'s capex has grown at a 27.9% compound annual growth rate (CAGR), from $6.56M to $13.71M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.